Substance Use Disorders: Clinical Application | March 12, 2024
Date of Presentation: March 12, 2024
Type: Past Presentation Training
Audience: Clinical
Program: Ending the Epidemics in Indian Country ECHO Program
Keywords: #fentanyl #harm reduction #medications for opioid use disorder #methamphetamine #MOUD #risk reduction #Screening #substance use disorder #SUD #SUD treatment
In this series of presentations, Dr. Jessica Gregg, MD, PhD, provides a comprehensive overview of Substance Use Disorders, including Medications for Opioid Use Disorder, Methamphetamine Use Disorder, the rise of fentanyl, and share ways to effectively integrate evidence-based clinical strategies into primary care.
Recording:
Presented by:
Jessica Gregg, MD, PhD
Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for Fora Health in Portland, Oregon.
Resources Provided:
- Opioid and Methamphetamine Use Disorders: Diagnosis and Treatment (Presentation Slides)
- Hospital Standards of Care for People with Substance Use Disorder (NEJM)
Date added: February 15, 2024
